We look at some of the highlights of our Twitter chat (#TalkFungi), where we questioned Ilan Schwartz, Andrej Spec, Rebecca Drummond and Jessie Uehling about all things mycology.
Browsing: Disease Area > Fungal
Join us for our Twitter chat with experts in the field on the 2 October at 15:00 BST/ 10:00 EDT, discussing fungal diseases, their burden and the challenges that face them #TalkFungi.
In this interview, take a look behind the scenes of a recent Future Microbiology paper on the emergence of antifungal resistance and what can be done in response with author, Justin Beardsley.
In this interview, we speak to Ana Litvintseva, a Medical Mycologist and Team Lead at the Centers for Disease Control and Prevention (CDC; GA, USA) about Candida auris, its emergence and the challenges it presents.
Multi-use patient equipment, such as thermometers, has been linked to one of the largest outbreaks of the emerging drug-resistant fungal pathogen Candida auris to-date.
Results from the Phase II STRIVE trial demonstrates favorable safety, tolerability and efficacy of the antifungal drug, rezafungin.
The Microbe Directory is a collective research effort aiming to profile over 7,000 microbes in order to provide further information for any researchers carrying out metagenomic analyses. We spoke to two of the Project Leaders, Heba Shaaban and David Westfall about the project, how it’s being used in research and how you can get involved.
Infectious diseases remain a major cause of mortality across the globe, so if pathogens could therefore be harnessed as a weapon, the implications would certainly be severe and far-reaching. Find out more about biothreats and bioterrorism in our explainer.
To round up 2017, we asked our Expert panel to choose their top papers from the year. Here, you can discover these articles and the reasons why they were chosen.